NCT00055523已完成2 期
A Phase II Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- Abbott
- 入组人数
- 300
- 试验地点
- 84
- 主要终点
- (achievement of a CDAI <150) of adalimumab 40 mg and 80 mg vs. placebo at Week 4.
研究概览
简要总结
Purpose of the study is to test whether adalimumab can induce clinical remission in subjects with active Crohn's disease when compared to placebo (an inactive substance)
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
(achievement of a CDAI <150) of adalimumab 40 mg and 80 mg vs. placebo at Week 4.
comparison of the induction of clinical remission
次要结局
未报告次要终点
研究者
研究点 (84)
Loading locations...
相似试验
Unknown
不适用
UVB-311nm After Initial Slow Response to Adalimumab in PsoriasisPsoriasisNCT00638469Medical University of Graz10
已完成
3 期
Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's DiseaseCrohn's DiseaseNCT00105300Abbott300
已完成
3 期
Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With MethotrexateRheumatoid ArthritisNCT00647920Abbott47
已完成
2 期
A Phase II Trial of Avelumab in Patients With Recurrent or Progressive OsteosarcomaOsteosarcomaNCT03006848St. Jude Children's Research Hospital19
招募中
不适用
A Study of Adalimumab in Acute Vogt-Koyanagi-Harada DiseaseVogt-Koyanagi-Harada DiseaseAdalimumabNCT05590416Tianjin Medical University15